이력관리 솔루션 시장 : 구성 요소, 기술, 용도, 최종 이용 산업, 기업 규모, 도입 형태별 - 세계 시장 예측(2026-2032년)

The Track & Trace Solutions Market is projected to grow by USD 18.56 billion at a CAGR of 13.21% by 2032.

Track & trace solutions have moved from operational tools to strategic infrastructure for pharmaceutical, healthcare, and life sciences supply chains. Serialization, aggregation, electronic product code standards, and secure data exchange help organizations verify product identity, reduce counterfeiting risk, strengthen recall, and meet strict compliance obligations across complex distribution networks.

Regulatory pressure remains a primary adoption driver. The U.S. Drug Supply Chain Security Act requires interoperable, electronic tracing for prescription medicines; the European Union Falsified Medicines Directive requires safety features and verification for many medicines; and multiple Asia-Pacific markets continue to expand serialization, reporting, and product authentication requirements. These mandates make track and trace platforms essential for manufacturers, contract manufacturing organizations, wholesalers, pharmacies, and healthcare providers seeking trusted product visibility from production to dispensing.

Transformative Shifts in the Track & Trace Landscape

The track & trace landscape is shifting from batch-level visibility to unit-level, event-driven intelligence. Organizations are replacing fragmented barcode repositories with interoperable serialization platforms that connect enterprise resource planning, warehouse management, manufacturing systems, quality systems, and third-party logistics networks.

The most transformative change is the movement toward standards-based data sharing. GS1 identifiers, electronic product codes, 2D DataMatrix barcodes, RFID, and secure APIs are enabling real-time product verification, aggregation, decommissioning, returns verification, and exception management across trading partners. This shift improves compliance while supporting business outcomes such as faster recalls, reduced diversion, improved inventory accuracy, and stronger patient safety controls.

Cumulative Impact of Artificial Intelligence on Track & Trace

Artificial intelligence is expanding the value of track & trace solutions beyond compliance reporting. AI-enabled analytics can identify abnormal shipment routes, suspicious verification patterns, inventory mismatches, duplicate serial number events, returns anomalies, and temperature-excursion risks before they escalate into product quality or patient safety events.

The cumulative impact is a more predictive and responsive supply chain. Machine learning models can improve demand planning, automate exception triage, and support risk-based investigations by correlating serialization events with carrier data, warehouse scans, returns activity, cold chain records, and quality documentation. As AI adoption increases, governance, explainability, cybersecurity, data integrity, and validated system controls remain essential for regulated healthcare environments.

Key Regional Insights for Track & Trace Solutions

Asia-Pacific is a high-priority track & trace region as China, India, Japan, Australia, and South Korea strengthen healthcare digitization, product authentication, and export compliance. China's pharmaceutical manufacturing scale and digital regulatory infrastructure, India's role as a major medicine exporter, Japan's strong quality systems, Australia's advanced healthcare governance, and South Korea's technology-led distribution environment all support broader use of serialization, aggregation, barcode verification, and analytics-enabled traceability.

North America remains one of the most mature regions, led by the United States DSCSA framework and Canada's advanced pharmaceutical distribution ecosystem. Europe benefits from the EU Falsified Medicines Directive and established verification infrastructure, while the United Kingdom continues to align medicine traceability with patient safety, secure dispensing, and supply resilience priorities. Latin America is advancing through Brazil and Mexico, where pharmaceutical regulation, anti-counterfeit initiatives, and modernization of healthcare distribution support adoption. The Middle East is gaining momentum as GCC healthcare modernization and national digital health strategies elevate medicine verification. Africa is increasingly prioritizing secure medicine distribution and digital verification, particularly as global health authorities continue to highlight risks associated with substandard and falsified medical products in low- and middle-income markets.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are adopting track & trace solutions as regional pharmaceutical trade, e-commerce healthcare distribution, and government digitization accelerate. Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines are increasingly focused on product authentication, import control, serialization readiness, and supply chain visibility to improve regulatory oversight and patient safety.

The GCC is investing in advanced healthcare infrastructure, national medicine verification, and digital health platforms, making traceability a strategic priority across regulated pharmaceutical distribution. The European Union has one of the world's most structured pharmaceutical verification environments through the Falsified Medicines Directive, which has strengthened verification at dispensing points and across supply chains. BRICS countries are shaping adoption through large manufacturing bases, expanding public health systems, and rising demand for secure domestic and export supply chains. G7 markets set high expectations for quality, cybersecurity, interoperability, and pharmaceutical governance, while NATO member countries add resilience considerations as medicine availability, emergency preparedness, and secure logistics become part of broader critical infrastructure planning.

Key Country Insights for Track & Trace Adoption

The United States is defined by DSCSA-driven interoperability, electronic product tracing, verification, and authorized trading partner requirements, while Canada emphasizes secure healthcare distribution, strong compliance culture, and product integrity across regulated supply channels. Mexico and Brazil are expanding traceability efforts to reduce counterfeit exposure, improve regulated pharmaceutical trade, and enhance oversight of medicine distribution. The United Kingdom, Germany, France, Italy, and Spain benefit from mature European verification practices and established pharmacy-level authentication processes, while Russia maintains country-specific serialization and digital marking requirements that influence local compliance architecture.

China and India are pivotal because of their manufacturing scale, export role, and domestic healthcare demand. China's digital regulatory systems and India's export-focused pharmaceutical ecosystem make product-level visibility, aggregation, and secure data exchange important for both domestic control and international compliance. Japan, Australia, and South Korea combine advanced digital infrastructure with strong quality expectations, supporting adoption of serialization, RFID, barcode verification, and analytics-enabled traceability. Across these countries, investment priorities vary, but the common requirement is accurate product identity, interoperable data exchange, rapid exception resolution, and reliable evidence of supply chain custody.

Actionable Recommendations for Industry Leaders

Industry leaders should treat track & trace as an enterprise capability rather than a compliance project. Priority actions include adopting GS1-aligned identifiers, validating serialization data quality, integrating trading partners through secure APIs, and building governance for master data, event data, exception workflows, access controls, and audit readiness.

Organizations should also invest in AI-enabled anomaly detection, cybersecurity controls, scalable cloud architecture, and validated integration between packaging lines, enterprise systems, warehouse platforms, logistics providers, and dispensing networks. The strongest programs connect compliance with business value by using traceability data to improve recall speed, reduce losses from diversion, optimize inventory, strengthen returns verification, and build trust with regulators, providers, pharmacies, and patients.

Research Methodology

This executive summary is based on a secondary research methodology using verified public sources, regulatory frameworks, industry standards, and market-structure analysis. Core references include established requirements such as the U.S. DSCSA, EU Falsified Medicines Directive, GS1 identification and data exchange standards, national serialization and digital marking regulations, and public health guidance from recognized authorities on medicine quality, anti-counterfeiting, and supply chain security.

The analysis evaluates demand drivers, technology adoption, regional regulation, supply chain digitization, interoperability, cybersecurity, AI readiness, and industry risk factors. Findings are synthesized qualitatively to support strategic planning without relying on unverified claims, market-size estimates, market share statements, or unsupported growth forecasts.

Conclusion

Track & trace solutions are now central to pharmaceutical integrity, patient safety, and resilient healthcare supply chains. Regulatory mandates established the foundation, but the next wave of value will come from interoperable data, AI-driven risk detection, secure serialization networks, and trusted collaboration across trading partners.

Organizations that modernize now will be better positioned to meet evolving compliance expectations, combat counterfeiting, improve recall performance, strengthen returns verification, and build trusted digital supply networks across global markets.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Track & Trace Solutions Market, by Component

• 7.1. Hardware
  • 7.1.1. Antennas
  • 7.1.2. Printers
  • 7.1.3. Readers
  • 7.1.4. Tags
• 7.2. Services
  • 7.2.1. Managed Services
  • 7.2.2. Professional Services
• 7.3. Software

8. Track & Trace Solutions Market, by Technology

• 8.1. Barcode
• 8.2. GPS
  • 8.2.1. Cellular
  • 8.2.2. Satellite
• 8.3. RFID
  • 8.3.1. Active
  • 8.3.2. Passive

9. Track & Trace Solutions Market, by Application

• 9.1. Aggregation
• 9.2. Anti Counterfeiting
• 9.3. Asset Tracking
• 9.4. Inventory Management
• 9.5. Regulatory Compliance
• 9.6. Serialization
• 9.7. Supply Chain Visibility

10. Track & Trace Solutions Market, by End-Use Industry

• 10.1. Automotive
• 10.2. Electronics
• 10.3. Food & Beverage
• 10.4. Healthcare
• 10.5. Logistics & Transportation
• 10.6. Manufacturing
• 10.7. Retail

11. Track & Trace Solutions Market, by Enterprises Size

• 11.1. Large Enterprises
• 11.2. Small & Medium Enterprises

12. Track & Trace Solutions Market, by Deployment Mode

• 12.1. Cloud
• 12.2. On Premise

13. Track & Trace Solutions Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Track & Trace Solutions Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Track & Trace Solutions Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. ABB Ltd.
• 17.2. Accenture PLC
• 17.3. ACG Group
• 17.4. Amazon Web Services, Inc.
• 17.5. Antares Vision S.p.A.
• 17.6. Axway Inc.
• 17.7. Bar Code India Limited
• 17.8. Best Barcode System Private Limited
• 17.9. Cognex Corporation
• 17.10. Datalogic S.p.A.
• 17.11. Domino Printing Sciences PLC by Brother Industries
• 17.12. Dynamsoft Corporation
• 17.13. Grant-Soft Ltd.
• 17.14. HOLOSTIK GROUP
• 17.15. Honeywell International Inc.
• 17.16. International Business Machines Corporation
• 17.17. Jekson Vision Pvt. Ltd.
• 17.18. Kevision Group
• 17.19. Laetus GmbH by Danaher Corporation
• 17.20. Marchesini Group S.p.A.
• 17.21. Mettler-Toledo International Inc.
• 17.22. Microsoft Corporation
• 17.23. Monarch Graphics
• 17.24. NeuroTags Inc.
• 17.25. Open Text Corporation
• 17.26. Optel Group
• 17.27. Oracle Corporation
• 17.28. Precoro, Inc.
• 17.29. Robert Bosch GmbH
• 17.30. SAP SE
• 17.31. SATO Holdings Corporation
• 17.32. Siemens AG
• 17.33. Systech International by Dover Corporation
• 17.34. The Chemours Company
• 17.35. Trace and Track
• 17.36. TraceLink, Inc.
• 17.37. VISIOTT Technologie GmbH
• 17.38. VPL, Inc.
• 17.39. WIPOTEC GmbH
• 17.40. Wipro Limited
• 17.41. Zebra Technologies Corporation